Ted W Love

Insider Reports History

Location
South San Francisco, CA
Signature
By: /s/Paz Dizon, as attorney in fact For: Ted W. Love
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ted W Love:

Company Role Class Num Shares Value Price $ Report Date Ownership
Royalty Pharma plc Director Class A Ordinary Shares 53,848 $1,720,443 $31.95 13 May 2025 Direct
Royalty Pharma plc Director Class A Ordinary Shares 46,234 $1,397,575 $30.23 07 Jun 2024 Direct
GILEAD SCIENCES, INC. Director Common Stock 4,338 $449,546 $103.63 07 May 2025 Direct
Jazz Pharmaceuticals plc Director Ordinary Shares 1,527 $293,184 $192.00 26 Feb 2026 Direct
Structure Therapeutics Inc. Director Share Option (right to buy) 51,804 23 Jun 2025 Direct
GILEAD SCIENCES, INC. Director Non-qualified Stock Option (Right to Buy) 12,648 08 May 2024 Direct
GILEAD SCIENCES, INC. Director Non-qualified Stock Option (Right to Buy) 6,809 07 May 2025 Direct
Global Blood Therapeutics, Inc. President and CEO, Director Common Stock 0 $46.99 05 Oct 2022 By Daughter
Global Blood Therapeutics, Inc. President and CEO, Director Common Stock 0 $46.99 05 Oct 2022 By Trust 1
Global Blood Therapeutics, Inc. President and CEO, Director Common Stock 0 $46.99 05 Oct 2022 By Trust 2
Global Blood Therapeutics, Inc. President and CEO, Director Common Stock 0 $46.99 05 Oct 2022 By Trust 3
Global Blood Therapeutics, Inc. President and CEO, Director Common Stock 0 $46.99 05 Oct 2022 Direct
Global Blood Therapeutics, Inc. President and CEO, Director Restricted Stock Units 0 05 Oct 2022 Direct
Global Blood Therapeutics, Inc. President and CEO, Director Stock Option (Right to Buy) 0 05 Oct 2022 Direct
Seagen Inc. Director Common Stock 0 $229.00 14 Dec 2023 Direct
Seagen Inc. Director Restricted Stock Units 0 $229.00 14 Dec 2023 Direct
Seagen Inc. Director Stock Options (Right to Buy) 0 14 Dec 2023 Direct

Insider Reports Filed by Ted W Love

Symbol Company Period Transactions Value $ Form Type Role Filing Time
JAZZ Jazz Pharmaceuticals plc 26 Feb 2026 1 $0 4 Director 02 Mar 2026, 17:09
JAZZ Jazz Pharmaceuticals plc 01 Dec 2025 0 $0 3 Director 10 Dec 2025, 17:03
GPCR Structure Therapeutics Inc. 23 Jun 2025 1 $0 4 Director 25 Jun 2025, 17:45
RPRX Royalty Pharma plc 13 May 2025 1 $0 4 Director 14 May 2025, 17:11
GILD GILEAD SCIENCES, INC. 07 May 2025 2 $0 4 Director 08 May 2025, 18:22
GPCR Structure Therapeutics Inc. 25 Jun 2024 1 $0 4 Director 27 Jun 2024, 16:15
RPRX Royalty Pharma plc 07 Jun 2024 1 $0 4 Director 10 Jun 2024, 16:16
GILD GILEAD SCIENCES, INC. 08 May 2024 2 $0 4 Director 09 May 2024, 17:30
GILD GILEAD SCIENCES, INC. 02 Feb 2024 2 $0 4 Director 06 Feb 2024, 18:01
GILD GILEAD SCIENCES, INC. 01 Feb 2024 0 $0 3 Director 06 Feb 2024, 16:15
/report/000095017023070880-love-ted-w-2023-12-14 Seagen Inc. 14 Dec 2023 6 -$974,395 4 Director 15 Dec 2023, 18:39
GPCR Structure Therapeutics Inc. 03 Aug 2023 1 $0 4 Director 04 Aug 2023, 17:34
GPCR Structure Therapeutics Inc. 03 Aug 2023 0 $0 3 Director 04 Aug 2023, 17:29
RPRX Royalty Pharma plc 23 Jun 2023 1 $0 4 Director 26 Jun 2023, 16:11
/report/000120331123000062-love-ted-w-2023-05-31 Seagen Inc. 31 May 2023 1 $0 4 Director 02 Jun 2023, 18:22
/report/000089924322033149-love-ted-w-2022-10-05 Global Blood Therapeutics, Inc. 05 Oct 2022 18 $0 4 President and CEO, Director 06 Oct 2022, 16:15
/report/000089924322032261-love-ted-w-2022-09-27 Global Blood Therapeutics, Inc. 27 Sep 2022 6 +$299,972 4 President and CEO, Director 29 Sep 2022, 20:45
/report/000089924322030476-love-ted-w-2022-09-01 Global Blood Therapeutics, Inc. 01 Sep 2022 5 -$626,980 4 President and CEO, Director 06 Sep 2022, 19:00
/report/000089924322027637-love-ted-w-2022-08-01 Global Blood Therapeutics, Inc. 01 Aug 2022 4 -$324,583 4 President and CEO, Director 03 Aug 2022, 18:01
RPRX Royalty Pharma plc 24 Jun 2022 1 $0 4 Director 24 Jun 2022, 16:57
/report/000089924322018464-love-ted-w-2022-05-13 Seagen Inc. 13 May 2022 2 $0 4 Director 17 May 2022, 19:32
/report/000089924322009236-love-ted-w-2022-03-01 Global Blood Therapeutics, Inc. 01 Mar 2022 7 -$100,405 4 President and CEO, Director 03 Mar 2022, 19:51
/report/000089924322004637-love-ted-w-2022-02-01 Global Blood Therapeutics, Inc. 01 Feb 2022 5 -$308,874 4 President and CEO, Director 03 Feb 2022, 16:47
/report/000089924321035219-love-ted-w-2021-09-01 Global Blood Therapeutics, Inc. 01 Sep 2021 3 -$139,788 4 President and CEO, Director 03 Sep 2021, 20:00
/report/000089924321037666-love-ted-w-2021-08-01-restatement Global Blood Therapeutics, Inc. 01 Aug 2021 5 -$405,932 4/A President and CEO, Director 24 Sep 2021, 19:00
RPRX Royalty Pharma plc 25 Jun 2021 1 $0 4 Director 29 Jun 2021, 20:43
/report/000120331121000033-love-ted-w-2021-05-14 Seagen Inc. 14 May 2021 2 $0 4 Director 18 May 2021, 19:28
/report/000089924322001260-love-ted-w-2016-07-01-restatement Global Blood Therapeutics, Inc. 01 Jul 2016 1 -$84,391 4/A President and CEO, Director 06 Jan 2022, 17:57